Donate Help Contact The AHA Sign In Home
American Heart Association
Stroke
Search: search_blue_button Advanced Search
Stroke. 2009;40:94-99
Published online before print November 13, 2008, doi: 10.1161/STROKEAHA.108.526996
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
40/1/94    most recent
STROKEAHA.108.526996v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Cordonnier, C.
Right arrow Articles by Salman, R. A.-S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Cordonnier, C.
Right arrow Articles by Salman, R. A.-S.
Related Collections
Right arrow CT and MRI
Right arrow Acute Stroke Syndromes
Right arrow Intracerebral Hemorrhage

(Stroke. 2009;40:94.)
© 2009 American Heart Association, Inc.


Original Contributions

Improving Interrater Agreement About Brain Microbleeds

Development of the Brain Observer MicroBleed Scale (BOMBS)

Charlotte Cordonnier, PhD; Gillian M. Potter, FRCR; Caroline A. Jackson, MSc; Fergus Doubal, MRCP; Sarah Keir, MD; Cathie L.M. Sudlow, DPhil; Joanna M. Wardlaw, FMedSci Rustam Al-Shahi Salman, PhD

From Department of Neurology and Stroke Unit (C.C.), Lille University Hospital, France; Division of Clinical Neurosciences (C.C., G.M.P., C.A.J., F.D., S.K., C.L.M.S., J.M.W., R.A.S.S.), University of Edinburgh, UK.

Correspondence to Rustam Al-Shahi Salman, Bramwell Dott Building, Division of Clinical Neurosciences, Western General Hospital, Edinburgh EH4 2XU, UK. E-mail Rustam.Al-Shahi{at}ed.ac.uk

Background and Purpose— If the diagnostic and prognostic significance of brain microbleeds (BMBs) are to be investigated and used for these purposes in clinical practice, observer variation in BMB assessment must be minimized.

Methods— Two doctors used a pilot rating scale to describe the number and distribution of BMBs (round, low-signal lesions, <10 mm diameter on gradient echo MRI) among 264 adults with stroke or TIA. They were blinded to clinical data and their counterpart’s ratings. Disagreements were adjudicated by a third observer, who informed the development of a new Brain Observer MicroBleed Scale (BOMBS), which was tested in a separate cohort of 156 adults with stroke.

Results— In the pilot study, agreement about the presence of ≥1 BMB in any location was moderate ({kappa}=0.44; 95% CI, 0.32–0.56), but agreement was worse in lobar locations ({kappa}=0.44; 95% CI, 0.30–0.58) than in deep ({kappa}=0.62; 95% CI, 0.48–0.76) or posterior fossa locations ({kappa}=0.66; 95% CI, 0.47–0.84). Using BOMBS, agreement about the presence of ≥1 BMB improved in any location ({kappa}=0.68; 95% CI, 0.49–0.86) and in lobar locations ({kappa}=0.78; 95% CI, 0.60–0.97).

Conclusion— Interrater reliability concerning the presence of BMBs was moderate to good, and could be improved with the use of the BOMBS rating scale, which takes into account the main sources of interrater disagreement identified by our pilot scale.


Key Words: brain microbleed • rating scale • interrater reliability • classification • stroke